Article
Infusion of donor-derived CD8+ memory T cells for relapse following allogeneic hematopoietic cell transplantation.
Blood advances - 27 Mar 2018
Muffly Lori, Sheehan Kevin, Armstrong Randall, Jensen Kent, Tate Keri, Rezvani Andrew R, Miklos David, Arai Sally, Shizuru Judith, Johnston Laura, Meyer Everett, Weng Wen-Kai, Laport Ginna G, Negrin Robert S, Strober Sam, Lowsky Robert
Abstract excerpt
Murine models showed that CD8+CD44hi memory T (TM) cells could eradicate malignant cells without inducing graft-versus-host disease (GVHD). We evaluated the feasibility and safety of infusing freshly isolated and purified donor-derived phenotypic CD8+ TM cells into adults with disease relapse after allogeneic hematopoietic cell transplantation (HCT). Phenotypic CD8 TM cells were isolated after unmobilized donor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
